DexCom (NASDAQ: DXCM) reported Q2 EPS of ($0.05), $0.02 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $93.2 million versus the consensus estimate of $84.81 million.

For earnings history and earnings-related data on DexCom (DXCM) click here.